Muscle Pathology

Endoret® (PRGF®) technology is suitable for the treatment of muscle injuries. Its application as an outpatient procedure reduces the recovery time for this type of injury with an almost zero rate of recurrence.

Endoret® (PRGF®) contains multiple growth factors that stimulate different steps of myogenesis, including proliferation, differentiation, migration and the fusion of muscle cells.


  • Muscle tears


  • Reduces pain and swelling
  • Reduces the healing time
  • Reduces fibrosis
  • Reduces the rate of recurrence
  • Clinical efficacy in tendinopathy and ligament injuries confirmed by publications using Endoret® (PRGF®) technology